Report cover image

Global Intravenous Immunoglobulin(IVIg) Therapy Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 120 Pages
SKU # APRC20353961

Description

Summary

According to APO Research, The global Intravenous Immunoglobulin(IVIg) Therapy market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Intravenous Immunoglobulin(IVIg) Therapy include TEIJIN LIMITED, Baxter, Biotest, Boya-Bio, CNBG, CSL Plasma, Grifols, Kamada and Kedrion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin(IVIg) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin(IVIg) Therapy.

The Intravenous Immunoglobulin(IVIg) Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Immunoglobulin(IVIg) Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Intravenous Immunoglobulin(IVIg) Therapy Segment by Company

TEIJIN LIMITED
Baxter
Biotest
Boya-Bio
CNBG
CSL Plasma
Grifols
Kamada
Kedrion
LFB Group
Nanyue Biopharming
Octapharma
Sinopharm
Beijing Tiantan Biological Products
Guangdong Shuagnlin Bio-pharmacy
Hualan Bio
Shanghai RAAS
Weiguang Biological
Taibang Biologic Group
Takeda

Intravenous Immunoglobulin(IVIg) Therapy Segment by Type

5g/100ml
2.5g/50ml
1g/20ml
10g/200ml
1.25g/25ml
Others

Intravenous Immunoglobulin(IVIg) Therapy Segment by Application

Autoimmune Disease
Immunodeficiency
Acute Infection
Others

Intravenous Immunoglobulin(IVIg) Therapy Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin(IVIg) Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin(IVIg) Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin(IVIg) Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous Immunoglobulin(IVIg) Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Intravenous Immunoglobulin(IVIg) Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

120 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Estimates and Forecasts (2020-2031)
1.3 Intravenous Immunoglobulin(IVIg) Therapy Market by Type
1.3.1 5g/100ml
1.3.2 2.5g/50ml
1.3.3 1g/20ml
1.3.4 10g/200ml
1.3.5 1.25g/25ml
1.3.6 Others
1.4 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type
1.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type (2020-2031)
1.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Size Review by Type (2020-2025)
1.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2020-2025)
1.5.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2020-2025)
1.5.4 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Trends
2.2 Intravenous Immunoglobulin(IVIg) Therapy Industry Drivers
2.3 Intravenous Immunoglobulin(IVIg) Therapy Industry Opportunities and Challenges
2.4 Intravenous Immunoglobulin(IVIg) Therapy Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Intravenous Immunoglobulin(IVIg) Therapy Revenue (2020-2025)
3.2 Global Top Players by Intravenous Immunoglobulin(IVIg) Therapy Sales (2020-2025)
3.3 Global Top Players by Intravenous Immunoglobulin(IVIg) Therapy Price (2020-2025)
3.4 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Intravenous Immunoglobulin(IVIg) Therapy Major Company Production Sites & Headquarters
3.6 Global Intravenous Immunoglobulin(IVIg) Therapy Company, Product Type & Application
3.7 Global Intravenous Immunoglobulin(IVIg) Therapy Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market CR5 and HHI
3.8.2 Global Top 5 and 10 Intravenous Immunoglobulin(IVIg) Therapy Players Market Share by Revenue in 2024
3.8.3 2023 Intravenous Immunoglobulin(IVIg) Therapy Tier 1, Tier 2, and Tier 3
4 Intravenous Immunoglobulin(IVIg) Therapy Regional Status and Outlook
4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Size by Region
4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Volume by Region (2020-2025)
4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Value by Region (2020-2025)
4.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Forecasted Market Size by Region
4.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Volume by Region (2026-2031)
4.3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Value by Region (2026-2031)
4.3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Intravenous Immunoglobulin(IVIg) Therapy by Application
5.1 Intravenous Immunoglobulin(IVIg) Therapy Market by Application
5.1.1 Autoimmune Disease
5.1.2 Immunodeficiency
5.1.3 Acute Infection
5.1.4 Others
5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application
5.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application (2020-2031)
5.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Size Review by Application (2020-2025)
5.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2020-2025)
5.3.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2020-2025)
5.3.4 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 TEIJIN LIMITED
6.1.1 TEIJIN LIMITED Comapny Information
6.1.2 TEIJIN LIMITED Business Overview
6.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.1.5 TEIJIN LIMITED Recent Developments
6.2 Baxter
6.2.1 Baxter Comapny Information
6.2.2 Baxter Business Overview
6.2.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.2.5 Baxter Recent Developments
6.3 Biotest
6.3.1 Biotest Comapny Information
6.3.2 Biotest Business Overview
6.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.3.5 Biotest Recent Developments
6.4 Boya-Bio
6.4.1 Boya-Bio Comapny Information
6.4.2 Boya-Bio Business Overview
6.4.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.4.5 Boya-Bio Recent Developments
6.5 CNBG
6.5.1 CNBG Comapny Information
6.5.2 CNBG Business Overview
6.5.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.5.5 CNBG Recent Developments
6.6 CSL Plasma
6.6.1 CSL Plasma Comapny Information
6.6.2 CSL Plasma Business Overview
6.6.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.6.5 CSL Plasma Recent Developments
6.7 Grifols
6.7.1 Grifols Comapny Information
6.7.2 Grifols Business Overview
6.7.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.7.5 Grifols Recent Developments
6.8 Kamada
6.8.1 Kamada Comapny Information
6.8.2 Kamada Business Overview
6.8.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.8.5 Kamada Recent Developments
6.9 Kedrion
6.9.1 Kedrion Comapny Information
6.9.2 Kedrion Business Overview
6.9.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.9.5 Kedrion Recent Developments
6.10 LFB Group
6.10.1 LFB Group Comapny Information
6.10.2 LFB Group Business Overview
6.10.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.10.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.10.5 LFB Group Recent Developments
6.11 Nanyue Biopharming
6.11.1 Nanyue Biopharming Comapny Information
6.11.2 Nanyue Biopharming Business Overview
6.11.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.11.5 Nanyue Biopharming Recent Developments
6.12 Octapharma
6.12.1 Octapharma Comapny Information
6.12.2 Octapharma Business Overview
6.12.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.12.5 Octapharma Recent Developments
6.13 Sinopharm
6.13.1 Sinopharm Comapny Information
6.13.2 Sinopharm Business Overview
6.13.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.13.5 Sinopharm Recent Developments
6.14 Beijing Tiantan Biological Products
6.14.1 Beijing Tiantan Biological Products Comapny Information
6.14.2 Beijing Tiantan Biological Products Business Overview
6.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.14.5 Beijing Tiantan Biological Products Recent Developments
6.15 Guangdong Shuagnlin Bio-pharmacy
6.15.1 Guangdong Shuagnlin Bio-pharmacy Comapny Information
6.15.2 Guangdong Shuagnlin Bio-pharmacy Business Overview
6.15.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.15.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
6.16 Hualan Bio
6.16.1 Hualan Bio Comapny Information
6.16.2 Hualan Bio Business Overview
6.16.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.16.5 Hualan Bio Recent Developments
6.17 Shanghai RAAS
6.17.1 Shanghai RAAS Comapny Information
6.17.2 Shanghai RAAS Business Overview
6.17.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.17.5 Shanghai RAAS Recent Developments
6.18 Weiguang Biological
6.18.1 Weiguang Biological Comapny Information
6.18.2 Weiguang Biological Business Overview
6.18.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.18.5 Weiguang Biological Recent Developments
6.19 Taibang Biologic Group
6.19.1 Taibang Biologic Group Comapny Information
6.19.2 Taibang Biologic Group Business Overview
6.19.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.19.5 Taibang Biologic Group Recent Developments
6.20 Takeda
6.20.1 Takeda Comapny Information
6.20.2 Takeda Business Overview
6.20.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.20.5 Takeda Recent Developments
7 North America by Country
7.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
7.1.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025)
7.1.3 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2026-2031)
7.2 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
7.2.1 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2020-2025)
7.2.3 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
8.1.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025)
8.1.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2026-2031)
8.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
8.2.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2020-2025)
8.2.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
9.1.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025)
9.1.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
9.2.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
10.1.1 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025)
10.1.3 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2026-2031)
10.2 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
10.2.1 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2020-2025)
10.2.3 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
11.1.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025)
11.1.3 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
11.2.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Intravenous Immunoglobulin(IVIg) Therapy Value Chain Analysis
12.1.1 Intravenous Immunoglobulin(IVIg) Therapy Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Intravenous Immunoglobulin(IVIg) Therapy Production Mode & Process
12.2 Intravenous Immunoglobulin(IVIg) Therapy Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
12.2.3 Intravenous Immunoglobulin(IVIg) Therapy Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.